Support for Patients and Communities Reauthorization Act
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sign in to view Hilltelligence’s plain-English summary.
- SenateLatest
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- House
Considered as unfinished business. (consideration: CR H6836)
- House
Motion to reconsider laid on the table Agreed to without objection.
- House
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 386 - 37 (Roll no. 715). (text: 12/11/2023 CR H6790-6794)
- House
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 386 - 37 (Roll no. 715). (text: 12/11/2023 CR H6790-6794)
- House
DEBATE - The House proceeded with forty minutes of debate on H.R. 4531.
- House
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
- House
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
- House
Considered under suspension of the rules. (consideration: CR H6789-6797)
- House
Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 29 - 3.
- House
Committee Consideration and Mark-up Session Held
- House
Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
- House
Committee Consideration and Mark-up Session Held.
- House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- House
Introduced in House
Sign in to view Hilltelligence’s passage-probability analysis.
- The Controlled Substances Act (CSA): A Legal Overview for the 119th Congress
R45948 · Jan 22, 2025
- Xylazine and the Controlled Substances Act: Legal Considerations for Congress
LSB11202 · Jul 19, 2024
Nonpartisan Congressional Research Service products citing this bill.